A Dental Pain Study to Test the Effectiveness of a New Pain Reliever Medicine
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
To assess the safety and effectiveness one dose of a new pain reliever medicine (JNJ-10450232
at either the 250 or 1000 mg strength) compared with placebo (sugar pill) or acetaminophen
1000 mg after surgical removal of third molars. The primary endpoint will evaluate pain
relief effectiveness up to 6 hours after administration of the study drug.
Phase:
Phase 2
Details
Lead Sponsor:
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.